November 2006

Presence of Intrahepatic HBV DNA Does Not Predict Recurrence after Liver Transplantation  11/03/06

Low Risk of HBV Recurrence after Liver Transplantation in Patients Maintained on Antiviral Therapy  11/03/06

October

Non-viral Factors Associated with HCV Recurrence after Liver Transplantation

Hepatitis C Treatment after Liver Transplantation

Life Expectancy after Liver Transplantation

Bone Density after Transplantation

Women do better after Liver Transplants

Women Given Liver Transplants Outlive Male Recipients By Around 4 Years

August

Pegylated Interferon Plus Ribavirin Therapy in Patients with HCV Recurrence after Liver Transplantation

Diabetes is Associated with Hepatic Encephalopathy in Patients with HCV-Related Cirrhosis

Age Alone Does Not Affect Outcome of Liver Transplant in Elderly

FDA Warns About Eating Raw Wash. Oysters

Diabetes Increases Fibrosis in Patients Transplanted for Hep C

Liver Transplants:Researchers Aim To Cut The Need For Them In The Future

Tumor Debulking Predicts Liver Transplant Success

Hepatitis C Recurs Rapidly after Liver Transplant -

Hepatitis C-Related Liver Cancer Mortality on the Rise: Report

Risk Factors for Peritonitis after Liver Transplantation

Risk Factors for Infection and Pathogen Transmission from Liver Donors

Males Are More at Risk for Diabetes after Liver Transplantation
 

June

06-06-06 DDW

Fatigue Is a Major Problem After Liver Transplantation

The Effect of Liver Fibrosis and Cirrhosis on SVR in 4913 Patients with Hepatitis C: Results from the Win-R Trial -

• 201. Non-utilization of livers from deceased donors who successfully donate another solid organ: How often and the role of donor age and obesity
• 204. Race Influences Access to Liver Transplantation and Mortality on the Waiting-List
• 205. Psychosocial Characteristics of Living Liver Donors
• 206. Use Of Ethambutol And A Quinolone In Ppd Positive Patients With Advanced Cirrhosis Before Or After Liver Transplantation.
• Abstract T1217 – Colonic complications after liver transplant, an under appreciated significant problem?
• Abstract T1218 – Incidence, endoscopic findings and treatment of biliary tract complications after orthotopic liver transplantation - a single centre experience.
• Abstract T1219 – Endoscopic Treatment for Biliary Complications in Donors after Living-donor Liver Transplantation
• Abstract T1220 – Evaluation of transabdominal ultrasonography for biliary complications after liver transplantation in recipients with choledochocholedochostomy without T-tube
• Abstract T1221 – Predictive Factors For Graft And Patient Survival Following Liver Transplantation For Hepatitis C
• Abstract T1222 – Long-Term Outcome of Orthotopic Liver Transplantation in Cryptogenic Cirrhosis
• Abstract T1223 – Frequency of development of hepatocellular carcinoma and the utility of surveillance ultrasound examination in patients with end stage liver disease (ESLD) from hepatitis C cirrhosis on the liver transplantation waiting list.
• Abstract T1224 – Hepatitis B, tumor treatment and immunosuppression influence recurrence of hepatocellular carcinoma after liver transplantation

Retreatment with Peginterferon Alfa-2a (Pegasys) Plus Ribavirin of Nonresponders with Cirrhosis/Advanced Fibrosis to Peginterferon Alfa-2b (PegIntron)

- 5/23/06

Initial HCV Response in Patients with End Stage Renal Disease Treated with Pegasys Plus Ribavirin -

5/23/06

EASL: Pegasys/RBV In Post Liver Transplant for Recurrent HCV -

The challenge of progressive hepatitis C following liver transplantation -

What Factors Predict Survival in Patients with Hepatocellular Carcinoma and Cirrhosis Who Receive Liver Transplants? -

Immunosuppressive Therapy Affects Transplant Outcomes

Liver Transplantation: An Update

Chronic Hepatitis In Pediatric Liver Transplant Patients

Liver Transplants Can Be Successful In HIV Patients With Hepatitis B

Liver Assist Device - Arbios Expands Indications For SEPET(TM) Feasibility Trial

Living Donor Liver Transplant in High-Risk Patients Is Effective

Hepatitis C Recurs Rapidly after Liver Transplant

Clinical Outcomes of Living Donor Liver Transplantation for Hepatitis C Virus (HCV)-Positive Patients.

Liver Transplantation

XTL-6865 To prevent Hepatitis C Reinfection Following Liver Transplant

Differentiation grade predicts liver transplant survival

Recurrence of hepatitis C infection Post Transplantation: Where are we now? -

AASLD: Liver Transplant Articles AASLD